Image

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be analyzed to determine the differences in kinematics and continuous pain scores between Bertolotti patients and non-Bertolotti low back pain patients.

Eligibility

Inclusion Criteria:

Lower Back Pain Cohort

  • Positive diagnosis of sacroiliac pain or lumbosacral facet arthritis pain
  • Age ≥ 18 years

Bertolotti's Syndrome Cohort

  • Positive diagnosis of Bertolotti's Syndrome
  • Age ≥ 18 years
  • Positive imaging for Bertolotti's Syndrome
  • Previous analgesic injection results

Exclusion Criteria:

Lower Back Pain Cohort

  • History of spinal deformity, previous spinal surgeries, spinal infections
  • Pregnant women

Bertolotti's Syndrome Cohort

  • History of spinal deformity, previous spinal surgeries, spinal infections
  • Pregnant women

Study details
    Bertolotti's Syndrome
    Lower Back Pain

NCT06225583

The Cleveland Clinic

16 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.